The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Financial burden of cancer clinical trials: Impact of an equity program intervention.
 
Ryan David Nipp
No Relationships to Disclose
 
Daniel Finkelstein
No Relationships to Disclose
 
Elizabeth Powell
No Relationships to Disclose
 
Lisa Vittorio
No Relationships to Disclose
 
Nicole Birrer
No Relationships to Disclose
 
Bruce Allan Chabner
Leadership - PharmaMar
Stock and Other Ownership Interests - Agios; Biogen; Biomarin; Celgene; Epizyme; Pharmacyclics; Seagen
Honoraria - ARIAD; Epizyme; Lilly; Merrimack; PharmaMar
Consulting or Advisory Role - Epizyme; Merrimack; PharmaMar; Sanofi
Patents, Royalties, Other Intellectual Property - NIH patent (taxol)
Expert Testimony - Lilly
Travel, Accommodations, Expenses - ARIAD; Epizyme; Lilly; Merrimack; PharmaMar; Sanofi
 
Hang Lee
No Relationships to Disclose
 
Beverly Moy
Consulting or Advisory Role - MOTUS (I); Olympus (I)